
Kostal Pharma Labs Private Limited
This company manufactures and supplies pharmaceutical products, including veterinary bulk drugs and medicines.
This company manufactures and supplies pharmaceutical products, including veterinary bulk drugs and medicines.
Kostal Pharma Labs Private Limited (KPLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 December 2003 and has a history of 21 years and four months. Its registered office is in Godavari, Andhra Pradesh, India.
The Corporate was formerly known as Abhaya Medicine Mart Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.41 Cr.
The company currently has active open charges totaling ₹1.80 Cr. The company has closed loans amounting to ₹2.80 M, as per Ministry of Corporate Affairs (MCA) records.
Vishnu Remella, Kasiviswanadha Remella, and Lakshmi Remella serve as directors at the Company.
Godavari, Andhra Pradesh, India
+91-XXXXXXXXXX
U51397AP2003PTC042217
042217
Private Limited Indian Non-Government Company
12 Dec 2003
30 Sep 2024
31 Mar 2024
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kasiviswanadha Remella ![]() | Managing Director | 12-Dec-2003 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishnu Remella ![]() | Director | 12-Dec-2003 | Current |
Lakshmi Remella ![]() | Director | 29-Jun-2011 | Current |
Kostal Pharma Labs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.94% decrease. The company also saw a substantial fall in profitability, with a 92.26% decrease in profit. The company's net worth moved up by a moderate rise of 1.81%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Kostal Pharma Labs had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹1.80 Cr
₹0.28 Cr
Date | Lender | Amount | Status |
---|---|---|---|
27 Apr 2011 | Indian Overseas Bank | ₹1.80 Cr | Open |
01 Nov 2021 | Indian Overseas Bank | ₹2.80 M | Satisfied |
Kostal Pharma Labs has a workforce of 12 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kostal Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kostal Pharma Labs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kostal Pharma Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Kostal Pharma Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
A charge registered on 01 Nov 2021 via Charge ID 100503401 with Indian Overseas Bank was fully satisfied on 26 Feb 2024.
A charge with Indian Overseas Bank amounted to Rs. 0.28 Cr with Charge ID 100503401 was registered on 01 Nov 2021.
A charge with Indian Overseas Bank of Rs. 1.80 Cr registered on 27 Apr 2011 with Charge ID 10292126 was modified on 01 Nov 2021.
Lakshmi Remella was appointed as a Director was appointed as a Director on 29 Jun 2011 & has been associated with this company since 13 years 10 months .
Kostal Pharma Labs Private Limited was incorporated on 12 Dec 2003.
The authorized share capital of Kostal Pharma Labs Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.41 Cr.
Currently 3 directors are associated with Kostal Pharma Labs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Kostal Pharma Labs Private Limited is Plot No. 71 To 78 Industrial Park Phase I India, Peddapuram, Andhra Pradesh, 533437.
The corporate identification number (CIN) of Kostal Pharma Labs Private Limited is U51397AP2003PTC042217 and the company number is 042217 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Kostal Pharma Labs Private Limited has fallen by -19.94%.
As Per 2023 financial reports, 12 employees are currently employed by Kostal Pharma Labs Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Kostal Pharma Labs Private Limited has experienced an upsurge of 1.81%.
As per the financial statements for fiscal Year 2023, The total open charges for Kostal Pharma Labs Private Limited amount to ₹ 1.80 Cr.
The most recent Balance Sheet for Kostal Pharma Labs Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
RR
DK